Use of High-Dose Iron in Dialysis in US Tracks PIVOTAL Trial
The 2019 landmark PIVOTAL trial that established the safety and efficacy of higher-dose iron in patients on hemodialysis had little discernable impact on US practice, which already used higher doses.
Medscape Medical News
source https://www.medscape.com/viewarticle/968908?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/968908?src=rss
Comments
Post a Comment